Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

LIPAC Oncology Announces Completion of LiPax Trial for Bladder Cancer

americanpharmaceuticalreviewSeptember 24, 2020

Tag: LIPAC Oncology , Bladder cancer , LiPax , NMIBC

PharmaSources Customer Service